1. Jennifer S.
Drukteinis,
MD Eva C.
Gombos,
MD Sughra Raza,
MD Sona A.
Chikarmane,
MD, Arpita Swami,
MBBS,
Robyn L.
Birdwell,
MD
MR Imaging Assessment of the Breast after Breast Conservation Therapy: Distinguishing Benign from Malignant Lesions
2. Chikarmane SA,
Gombos EC,
Ahmed L,
Raza S,Griffin GK,
Birdwell RL.
Outcome of the probably benign (BI-RADS 3) magnetic resonance imaging assessment in the treated breast in women after lumpectomy and radiation therapy
3.Li J,
Dershaw DD,
Lee CH,
Joo S,
Morris EA.
Breast MRI after conservation therapy: usual findings in routine follow-up examinations.
AJR Am J Roentgenol 2010;195(3):799–807.
4.American College of Radiology.
ACR practiceguideline for the performance of contrast enhanced magnetic resonance imaging (MRI) of the breast.
5.Michael L.
Marinovich,
Nehmat Houssami,
Petra Macaskill,
Francesco Sardanelli,
Les Irwig,
Eleftherios P.
Mamounas,
Gunter von Minckwitz,
Meagan E.
Brennan,
Stefano Ciatto.
Meta-analysis of Magnetic Resonance Imaging in Detecting
Residual Breast Cancer After Neoadjuvant Therapy
6.Rubina M.
Trimboli
Luca A.
Carbonaro,
Francesco Cartia,
Giovanni Di Leob,
Francesco Sardanelli.
MRI of fat necrosis of the breast: The “black hole” sign at short tau inversion recovery
7.Brennan S,
Liberman L,
Dershaw DD,
Morris E.
Breast MRI screening of women with a personal history of breast cancer.
8.Soo Yeon Hahn, Eun Young Ko,
Boo-Kyung Han,
Jung Hee Shin,
Eun Sook Ko.
Role of diffusion-weighted imaging as an adjunct to
contrast-enhanced breast MRI in evaluating residual breast cancer
following neoadjuvant chemotherapy.